These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17278300)

  • 1. Bronchodilator use in asthma: the art of prescribing bronchodilators correctly, taking advantage of their differences and reducing risks.
    Godoy Fernandes AL
    J Bras Pneumol; 2006; 32(3):11-2. PubMed ID: 17278300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-acting beta2-agonist bronchodilators safety for asthma treatment].
    Giubergia V
    Arch Argent Pediatr; 2009 Aug; 107(4):291-3. PubMed ID: 19753432
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of oral terbutaline and fenoterol in asthma.
    Miller WC; Rice DL
    Ann Allergy; 1980 Jan; 44(1):15-8. PubMed ID: 7352688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Th 1165a (Berotec) in the prevention of bronchospasm induced with pneumoallergens].
    Melillo G; Cocco G; D'Amato G; Sales L; Di Ruggiero G
    Arch Monaldi; 1975; 30(5-6):390-401. PubMed ID: 12727
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
    Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
    Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchospasmolytic effect of adrenergic beta receptor agonists in bronchial asthma].
    Makel'skiĭ VV
    Ter Arkh; 1976; 40(2):57-60. PubMed ID: 9700
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of Terbutaline administered orally in the treatment of asthma].
    Charpin J; Aubert J; Gayrard P; Rocca-Serra JP; Leonardelli M; Razzouk H
    Mars Med; 1972; 109(11):681-2. PubMed ID: 4145412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhaled formoterol and budesonide on exacerbations of asthma.
    Salvi S
    N Engl J Med; 1998 Apr; 338(15):1072. PubMed ID: 9537880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of procaterol aerosol as an aerosolized beta 2-adrenergic bronchodilator in conscious guinea pigs].
    Arai Y; Nitta K; Shida T
    Arerugi; 1985 Nov; 34(11):999-1005. PubMed ID: 2867754
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenoterol: clinical trial of a new long acting bronchodilator.
    Emirgil C; Palmer K; VanVoorhies L; Wesson C; Sobol BJ
    Ann Allergy; 1977 Dec; 39(6):415-7. PubMed ID: 339786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in static and dynamic pulmonary volumes in patients with bronchial asthma treated with a new bronchodilator agent: Th 1165 a].
    Maiorano V; D'Angelo R; Frisotti A; Carnimeo N
    Torace; 1976 Jan; 18(1-2):20-39. PubMed ID: 996854
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenoterol, asthma deaths, and asthma severity.
    Pearce N; Burgess C; Crane J; Beasley R
    Chest; 1997 Oct; 112(4):1148-50. PubMed ID: 9377940
    [No Abstract]   [Full Text] [Related]  

  • 16. Eformoterol and bronchial hyperresponsiveness in mild asthma.
    Chung KF
    Br J Clin Pract Suppl; 1995 Sep; 81():14-5. PubMed ID: 8546888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physical work capacity of bronchial asthma patients treated with the preparation Berotek].
    Eremina SS; Solomonova LN
    Sov Med; 1975 Aug; (8):141-2. PubMed ID: 1233745
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous eformoterol and beta 2-receptor responsiveness.
    Sussman HS
    Br J Clin Pract Suppl; 1995 Sep; 81():16-7. PubMed ID: 8546889
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting beta 2-agonists: the new symptom controllers for asthma.
    Jenkins CR
    Med J Aust; 1999 Sep; 171(5):255-8. PubMed ID: 10495758
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long acting beta-2 agonists. Discussion of their use in asthma].
    Aumiller J
    MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.